These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life. Kinch Westerdahl A; Sjöblom J; Mattiasson AC; Rosenqvist M; Frykman V Circulation; 2014 Jan; 129(4):422-9. PubMed ID: 24243857 [TBL] [Abstract][Full Text] [Related]
23. The effect of spironolactone on ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators. Zarraga IG; Dougherty CM; MacMurdy KS; Raitt MH Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):739-47. PubMed ID: 22773022 [TBL] [Abstract][Full Text] [Related]
24. Electrophysiologist-implanted transvenous cardioverter defibrillators using local versus general anesthesia. Manolis AS; Maounis T; Vassilikos V; Chiladakis J; Cokkinos DV Pacing Clin Electrophysiol; 2000 Jan; 23(1):96-105. PubMed ID: 10666758 [TBL] [Abstract][Full Text] [Related]
32. Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II. Berenbom LD; Weiford BC; Vacek JL; Emert MP; Hall WJ; Andrews ML; McNitt S; Zareba W; Moss AJ Ann Noninvasive Electrocardiol; 2005 Oct; 10(4):429-35. PubMed ID: 16255753 [TBL] [Abstract][Full Text] [Related]
33. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697 [TBL] [Abstract][Full Text] [Related]
34. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators. Blaschke F; Knaus T; Celebi O; Krebs A; Nitardy A; Habedank D; Dietz R; Stockburger M Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study. Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH; Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672 [TBL] [Abstract][Full Text] [Related]
37. Near-Fatal ICD Lead Dysfunction with Implications for ICD Testing. Wutzler A; Attanasio P; Haverkamp W; Blaschke F Pacing Clin Electrophysiol; 2016 Jan; 39(1):105-6. PubMed ID: 26519249 [TBL] [Abstract][Full Text] [Related]
38. Undersensing of ventricular fibrillation due to interference between a pacemaker and defibrillator in the same patient. Van Casteren L; Huybrechts W; Willems R Europace; 2009 Oct; 11(10):1390-1. PubMed ID: 19654130 [TBL] [Abstract][Full Text] [Related]
39. Electrical Storms in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention. Escande W; Marijon E; Defaye P; Piot O; Leclercq C; Sadoul N; Deharo JC; Empana JP; Boveda S; Klug D J Am Coll Cardiol; 2016 Sep; 68(11):1248-1250. PubMed ID: 27609689 [No Abstract] [Full Text] [Related]
40. Impact of the implantable cardioverter-defibrillator on rehospitalizations. Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]